Becton, Dickinson and Company (BDX)
NYSE: BDX · IEX Real-Time Price · USD
234.72
-0.45 (-0.19%)
At close: Apr 15, 2024, 4:00 PM
235.70
+0.98 (0.42%)
Pre-market: Apr 16, 2024, 6:25 AM EDT

BDX Revenue

Becton, Dickinson and Company had revenue of $19.49B in the twelve months ending December 31, 2023, with 4.02% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $4.71B with 2.62% year-over-year growth. In the fiscal year ending September 30, 2023, Becton, Dickinson and Company had annual revenue of $19.37B with 2.66% growth.

Revenue (ttm)
$19.49B
Revenue Growth
+4.02%
P/S Ratio
3.48
Revenue / Employee
$267,014
Employees
73,000
Market Cap
67.81B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202319.37B502.00M2.66%
Sep 30, 202218.87B-261.00M-1.36%
Sep 30, 202119.13B3.06B19.02%
Sep 30, 202016.07B-1.22B-7.03%
Sep 30, 201917.29B1.31B8.18%
Sep 30, 201815.98B3.89B32.17%
Sep 30, 201712.09B-390.00M-3.12%
Sep 30, 201612.48B2.20B21.41%
Sep 30, 201510.28B1.84B21.74%
Sep 30, 20148.45B392.00M4.87%
Sep 30, 20138.05B346.00M4.49%
Sep 30, 20127.71B124.00M1.64%
Sep 30, 20117.58B459.62M6.45%
Sep 30, 20107.12B137.66M1.97%
Sep 30, 20096.99B89.10M1.29%
Sep 30, 20086.90B614.78M9.79%
Sep 30, 20076.28B544.82M9.49%
Sep 30, 20065.74B397.18M7.44%
Sep 30, 20055.34B406.09M8.23%
Sep 30, 20044.93B471.24M10.56%
Sep 30, 20034.46B503.15M12.70%
Sep 30, 20023.96B214.18M5.72%
Sep 30, 20013.75B127.85M3.53%
Sep 30, 20003.62B199.92M5.85%
Sep 30, 19993.42B301.54M9.67%
Sep 30, 19983.12B306.35M10.90%
Sep 30, 19972.81B40.77M1.47%
Sep 30, 19962.77B57.23M2.11%
Sep 30, 19952.71B153.06M5.98%
Sep 30, 19942.56B94.06M3.82%
Sep 30, 19932.47B100.09M4.23%
Sep 30, 19922.37B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
McKesson 301.51B
Cencora 271.58B
HCA Healthcare 64.97B
GSK 38.39B
Takeda Pharmaceutical 29.40B
Gilead Sciences 27.12B
IQVIA Holdings 14.98B
Zoetis 8.54B
Revenue Rankings